Using cost of infection as a tool to demonstrate a difference in prophylactic antibiotic efficacy: A prospective randomized comparison of the pharmacoecomonic effectiveness of ceftriaxone and cefotaxime prophylaxis in abdominal surgery

World Journal of Surgery

Volumn 29, Issue 1, 2005, Pages 18-24

  Woodfield, John C ^a   Van Rij, Andre M ^a   Pettigrew, Ross A ^a   Van Der Linden, Antje ^a   Bolt, Donna ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; METRONIDAZOLE;

ABDOMINAL SURGERY; ADULT; AGED; APPENDECTOMY; ARTICLE; CLINICAL TRIAL; COLORECTAL SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFECTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; WOUND INFECTION;

AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CEFOTAXIME; CEFTRIAXONE; COST OF ILLNESS; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; SURGICAL WOUND INFECTION; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

EID: 17744362270     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-004-7257-z     Document Type: Article

References (51)

1. M Angell 1985 Cost containment and the physician J.A.M.A. 254 1203
2. F Bochner NG Burgess D Martin 1996 Approaches to rationing drugs in hospitals; an Australian perspective Pharmacoeconomics 10 467
3. DM Eddy 1994 Rationing resources while improving quality J.A.M.A. 272 817
4. RP Wenzel 1992 Preoperative antibiotic prophylaxis N. Engl. J. Med. 326 337
5. JW Green RP Wenzel 1977 Postoperative wound infection: a controlled study of the increased duration of hospital stay and direct cost of hospitalization Ann. Surg. 185 264
6. LL Leape TA Brennan N Laird 1991 The nature of adverse events in hospitalized patients-results of the Harvard Medical Practice Study II N. Engl. J. Med. 324 377
7. FD Daschner 1984 The cost of hospital acquired infection J. Hosp. Infect. 5 Suppl A 27
8. DM Bamberger SL Dahl 1992 Impact of voluntary enforced compliance of third-generation use in a teaching hospital Arch. Intern. Med. 152 554
9. GMH Misan C Dollman DR Shaw 1995 Cephalosporin utilization review and evaluation Pharmacoeconomics 8 100
10. Procter C. Ceftriaxone usage in therapy and prophylaxis at Dunedin Hospital. Pharmacy Department Report, Dunedin Hospital. 1995;1
11. A Hishaddai C Armour 1995 Drug utilization review of the third generation cephalosporins. Focus on Ceftriaxone, Ceftazidime and Cefotaxime Drugs 50 423
12. McIntosh P. Ceftriaxone audit. Health Care Hawkes Bay Pharmacy expenditure report for the 1996/1997 financial year. 1997; 1
13. JN Hayman EC Sbravati 1985 Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions Am. J. Hosp. Pharm. 42 1343
14. Chau PY, Ng WWS. Ceftriaxone in-vitro activity against important clinical isolates in comparison with other new cephalosporins. Symposium: Progress in therapy of bacterial infections. A new cephalosporin: ceftriaxone. Excerpta Medica Asia Pacific Congress series No 19
15. RN Jones AL Barry KE Aldridge 1987 Comparative antimicrobial activity of aminothiazolyl methoxyimino cephatosporins against anaerobic bacteria, including 100 cefoxitin-resistant isolates Diagn. Microbiol. Infect. Dis. 8 157
16. JC Woodfield AM Van Van Rij RP Pettigrew 2003 A comparison of the prophylactic efficacy of ceftriaxone and cefotaxime in abdominal surgery Am. J. Surg. 185 45
17. APR Wilson T Treasure MF Sturridge 1986 A scoring method for postoperative wound infections for use in clinical trials of antibiotic prophylaxis Lancet 1 8476 311
18. G Anderson C Baldiston S Woods 1996 A cost effectiveness evaluation of 3 antimicrobial regimens for the prevention of infective complications after abdominal surgery Arch. Surg. 131 744
19. P Davey B Lynch M Malek 1992 Cost-effectiveness of single dose cefotaxime plus metronidazole compared with three doses each of cefuroxime plus metronidazole for the prevention of wound infection after colorectal surgery J Antimicrob. Chemother. 30 855
20. D Coyle 1996 Statistical analysis in pharmacoeconomic studies. A review of current issues and standards Pharmacoeconomics 9 506
21. JC Hall J Mander K Christiansen 1988 Cost efficiency of a long acting cephalosporin agent Aust. N.Z. J. Surg. 58 733
22. HC Atkinson ST Chambers AM McGinlay 1989 Antibiotic therapy costs NZ. Med. J. 192 409
23. ETM Smyth JG Barr CA O'Neill 1995 An assessment of the hidden and total antibiotic costs for four parenteral cephatosporins Pharmacoeconomics 8 541
24. WT Morris 1994 Effectiveness of ceftriaxone versus cefoxitin in reducing chest and wound infections after upper abdominal operation Am. J. Surg. 167 391
25. WT Morris 1993 Ceftriaxone is more effective than gentamicin plus metronidazole prophylaxis in reducing wound and urinary tract infections after bowel operations Dis. Colon Rectum 36 826
26. JC Hall JL Hall 1996 Evaluation of a wound scoring method for patients undergoing cardiac surgery J. Hosp. Infect. 33 139
27. R Greif O Akca EP Horn 2000 Supplemental perioperative oxygen to reduce the incidence of surgical wound infection N. Engl. J. Med. 342:3 161
28. Murphy KA, Omo GL. $198,000 cost saving antibiotic substitution plan. American Society of Hospital Pharmacist-Midyear Clinical Meeting. 1992;27:P-5D
29. MJ Pearce EF Begg 1994 Hospital drug therapy cost containment through a preferred medicines list and drug utilization review system N. Z. Med. J. 107 974 101
30. W Lynch M Malek PG Davey 1992 Costing wound infection in a Scottish hospital Pharmacoeconomics 2 163
31. SR Norrby 1996 Cost effective prophylaxis of surgical infections Pharmacoeconomics 10 129
32. PG Davey SE Parker IK Crombie 1995 The cost effectiveness of amoxicillin/clavulanic acid as antibacterial prophylaxis in abdominal and gynecological surgery Pharmacoeconomics 7 347
33. C Solomon AM Van Rij SGK Packer 1994 Amputations in the surgical budget N. Z. Med. J. 107 973 78
34. DS Wakefield CM Helms RM Massanari 1988 Cost of nosocomial infection: relative contributions of laboratory, antibiotic and per diem costs in serious Staphylococcus aureus infections Am. J. Infect. Control 16 185
35. C Pena M Pujol R Pallares 1996 Estimation of costs attributable to nosocomial infection: prolongation of hospitalization and calculation of alternative costs Med. Clin. (Barc.) 106 441
36. F Daschner 1989 Cost effectiveness in hospital infection control - lessons for the 1990 s J. Hosp. Infect 13 325
37. RW Haley DR Schaberg KB Crossley 1981 Extra charges and prolongation of stay attributable to nosocomial infections: a prospective interhospital comparison Am. J. Med. 70 51
38. R Coello H Glenister J Fereres 1993 The cost of infection in surgical patients: a case-control study J. Hosp. Infect 25 239
39. DB Kirkland JP Briggs SL Trivette 1999 The impact of surgical site infections in the 1990 s: attributable mortality, excess length of hospitalization and extra costs Infect. Control Hosp. Epidemiol. 20 725
40. PJ Miller BM Farr JM Gwanltney 1989 Economic benefits of an effective infection control program: case study and proposal Rev. Infect. Dis. 11 284
41. LB Mason AG Garcia 1984 Hospital costs of surgical complications Arch Surg. 119 1065
42. RW Pinner RW Haley BA Blumenstein 1982 High cost of nosocomial infection Infection Control 3 143
43. NP Couch NL Tilney FD Moore 1978 The cost of misadventures in colon surgery: a model for the analysis of adverse outcomes in standard procedure Am. J. Surg. 135 641
44. RW Haley DR Schaberg SD Von Allmen 1980 Estimating the extra charges and prolongation of hospitalization due to nosocomial infections: a comparison of methods J. Infect. Dis. 141 248
45. GB Penin NJ Ehrenkranz 1988 Priorities for surveillance and cost-effective control of postoperative infection Arch. Surg. 123 1305
46. M Delgado-Rodriauez M Medina-Cuadros A Bueno-Cavanillas 1997 Comparison of two procedures to estimate the hospital stay attributable to nosocomial infection: matched cohort study versus analysis of covariance of the total unmatched cohort J. Clin. Epidemiol. 50 773
47. PG Davey ID Duncan D Edward 1988 Cost benefit analysis of cephradine and mezlocilin prophylaxis for abdominal and vaginal hysterectomy: Br. J. Obstet Gynecol. 95 1170
48. DJ Law SF Mishriki PJ Jeffrey 1990 The importance of surveillance after discharge from hospital in the diagnosis of postoperative wound infection Ann R. Coll. Surg. Engl. 72 207
49. W Lynch PG Davey M Malik 1992 Cost effectiveness analysis of the use of cholrhexidine detergent in preoperative whole body disinfection in wound infection prophylaxis J. Hosp. Infect. 21 179
50. DH Mitchell G Swift GL Gilbert 1999 Surgical wound infection surveillance: the importance of infections that develop after hospital discharge Aust. N. Z. Surg. 69 117
51. JC Hall 1999 Monitoring wound infection after surgery: the quest for useful information at a reasonable cost Aust. N. Z. J. Surg. 69 84